Varian’s Post

Join us for February's webinar on Radiotherapy with speaker Ryan Yeo, Radiation Therapist. Topics: - What is radiotherapy? - What do patients experience? - What do nurses need to know about radiotherapy and side effects in their patients? Register here 👉 https://loom.ly/GBMvYtQ #HealthcareWebinar #ProfessionalDevelopment #NursingWebinar #AlbertaHealthcare

For surgical oncologist Dr. Evan Glazer, “Specializing in Tomorrows” means offering the treatments of the future so patients can have a chance at a longer, healthier life. Dr. Glazer works with a multidisciplinary team to find the right treatment for the right patient at the right time – a complex process that involves understanding not only a patient’s diagnosis, but their priorities. Learn how Dr. Glazer uses advanced expertise and state-of-the-art surgical approaches to help patients have better outcomes and get back to life more quickly: https://lnkd.in/emP559Ni

DOES SIZE REALLY MATTER? Continued from previous post …(results of treatment) Patient chose the option of thermal ablation by pinhole approach ( RadioFrequency Ablation) after detailed discussion of all the options A-D . Achieved 80% reduction in volume ( from 240 ml to 48 ml) 6 months post 2 sessions of RFA StarMed Healthcare Patient is very happy with the results. Aiden Lee Jung Hwan Baek RFAMD #rfa #thyroid #thyroidawareness #thyroidhealth #interventionalradiology #interventionaloncology #minimallyinvasive

https://lnkd.in/gHxe87PG The optimal antithrombotic strategy to prevent CABG occlusion while minimizing bleeding risks remains uncertain. We conducted a review of randomized clinical trials and meta-analyses of antithrombotic therapy for patients with CABG, with the aim to inform clinical decision-making on the best choices for individual patients. #CABG #Cardiology #GraftFailure #Antithrombotics #Coronary

DCRI's Rob Mentz's focus on the "beans" at #ACC24 highlighted how GDMT, including RAASi and SGLT2, can potentially reduce CV and renal events, including hypokalemia and hyperkalemia, and lead to fewer discontinuations of other therapies. For patients with CKD, GDMT may result in an even greater benefit, though patients with the advanced condition should be closely monitored. #clinicaltrials #clinicalresearch #cardiology

🤔 Should patients have to wait anxiously for an appointment that only serves to give good news? We know that many of our specialists use our ‘Advice & Guidance’ feature to quickly respond to GPs and patients about non-urgent referrals. One important use case is when a GP makes an incidental finding on imaging or pathology, and a referral is sent to a specialist to investigate this further. Typically, time would first be spent making the appointment and freeing up schedules to attend it. Leading up to the appointment, the patient and their carers will be understandably anxious and unnecessarily so; They would simply be told the good news that this is just an incidental finding. Consultmed’s Advice & Guidance feature allows for asynchronous, secure communication back to the referrer. In this use case, immediate advice that the finding is normal would be communicated immediately and securely to the GP, saving valuable time, as well as unnecessary anxiety. 🗞️🗞️Check the link below to read Dr Pam Rachootin’s article! https://lnkd.in/gVySxbuc

On demand | A New Momentum for Renal Denervation: 2023 ESH Guidelines. Catch up here! ➡️ https://ow.ly/6ljy50QrF0i Dr Joost Daemen and Prof Dagmara Hering deliver a compelling discussion that provides an update on: ✅2023 ESH guidelines about Renal Denervation ✅The class of recommendation and level of evidence ✅Ultrasound RDN clinical evidence ✅Recommended patient pathways and hear case discussions #RDN #Cardiology #MedEd

✨ Major milestone! Inova Schar Heart and Vascular became the first in Northern Virginia to perform a coronary drug-coated procedure, offering a new treatment for in-stent restenosis (ISR)! ISR, where the coronary artery recloses due to a return of blockage at the stent site, is a complication that affects about 10% of patients undergoing coronary stent placement, reducing their quality of life. Traditionally, another stent is placed inside the existing one to reopen the blood vessel, but this increases the risk of ISR happening again. This new treatment procedure, led by our interventional cardiologists Behnam N. Tehrani, M.D., FSCAI, and Wayne Batchelor, MD, MHS, FSCAI, is a game-changer, delivering a targeted drug dose to dissolve ISR blockage without adding another stent. 🩺 Learn more: https://bit.ly/3zw8ut9 #restenosis #cardiology #heartandvascular #coronarystentplacement

Live TODAY | Latest Clinical Trial Updates for ATTR-CM and AL-CM!📊 Tune in at 14:00 GMT / 09:00 EST 🔗 https://ow.ly/stXO50QyJrg 🥼Dr Michelle Kittleson 🥼Dr Heather Landau 🥼Prof Dan Lenihan 🥼Prof Joe Carver Learn about ongoing clinical, emerging therapeutic modalities and the evolving landscape of patient management. #CardioOnc #Cardiology

🎙️NEW #ACC24 Late-Breaker Discussion 💫Dr Gregg Stone joins host Dr Harriette Van Spall to discuss the RELIEVE-HF trial. 📽️Watch in full here👉 https://ow.ly/IFoc50R9YGs 📊V-Wave inter-atrial shunt was safe but did not reduce symptoms or improve HF patient prognosis across 2y across the full range of LVEF. 📊Stratified analysis suggested that implantation is beneficial in #HFrEF, and harmful in patients with #HFpEF. #Cardiology #ClinicalTrial #CardioEd